These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8794438)

  • 1. Salmon calcitonin plus intravaginal estriol: an effective treatment for the menopause.
    Melis GB; Cagnacci A; Bruni V; Falsetti L; Jasonni VM; Nappi C; Polatti F; Volpe A
    Maturitas; 1996 May; 24(1-2):83-90. PubMed ID: 8794438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
    Reginster JY; Deroisy R; Lecart MP; Sarlet N; Zegels B; Jupsin I; de Longueville M; Franchimont P
    Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the long-term effects of oral estriol with the effects of conjugated estrogen, 1-alpha-hydroxyvitamin D3 and calcium lactate on vertebral bone loss in early menopausal women.
    Itoi H; Minakami H; Sato I
    Maturitas; 1997 Sep; 28(1):11-7. PubMed ID: 9391990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An effective regimen of intranasal salmon calcitonin in early postmenopausal bone loss.
    Gennari C; Agnusdei D; Montagnani M; Gonnelli S; Civitelli R
    Calcif Tissue Int; 1992 Apr; 50(4):381-3. PubMed ID: 1571851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of estriol for the treatment of bone loss in postmenopausal women].
    Nozaki M; Hashimoto K; Inoue Y; Sano M; Nakano H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Feb; 48(2):83-8. PubMed ID: 8718542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal salmon calcitonin blunts bone microstructure alterations in healthy postmenopausal women.
    Rizzoli R; Sigaud A; Azria M; Herrmann FR
    Osteoporos Int; 2015 Jan; 26(1):383-93. PubMed ID: 25566730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intranasal salmon calcitonin therapy on bone mass and bone turnover in early postmenopausal women: a dose-response study.
    Overgaard K
    Calcif Tissue Int; 1994 Aug; 55(2):82-6. PubMed ID: 7953984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
    Agnusdei D; Gonnelli S; Camporeale A; Batignani T; Nardi P; Ianes A; Gennari C
    Minerva Endocrinol; 1989; 14(3):169-76. PubMed ID: 2695815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
    Tascioglu F; Colak O; Armagan O; Alatas O; Oner C
    Rheumatol Int; 2005 Nov; 26(1):21-9. PubMed ID: 15688191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study.
    Gonnelli S; Cepollaro C; Montomoli M; Gennari L; Montagnani A; Palmieri R; Gennari C
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):55-61. PubMed ID: 9059558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive treatment of cortical bone loss with salmon nasal calcitonin in early postmenopausal women.
    Mango D; Ricci S; Manna P; Natili G; Dell'Acqua S
    Minerva Endocrinol; 1993 Sep; 18(3):115-21. PubMed ID: 8183178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of continuous and cyclic nasal calcitonin administration in ovariectomized women.
    Fioretti P; Gambacciani M; Taponeco F; Melis GB; Capelli N; Spinetti A
    Maturitas; 1992 Dec; 15(3):225-32. PubMed ID: 1465036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L; Kohlmeier L; Kent K; Marcus R
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of oral estriol for managing postmenopausal symptoms.
    Takahashi K; Manabe A; Okada M; Kurioka H; Kanasaki H; Miyazaki K
    Maturitas; 2000 Feb; 34(2):169-77. PubMed ID: 10714912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of estriol replacement therapy for climacteric women.
    Yang TS; Tsan SH; Chang SP; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 May; 55(5):386-91. PubMed ID: 7641124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin and postmenopausal bone loss.
    Reginster JY; Deroisy R; Lecart MP; Sarlet N; Fontaine MA; Albert A; Franchimont P
    Exp Gerontol; 1990; 25(3-4):349-56. PubMed ID: 2226670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient responsiveness to calcitonin salmon nasal spray: a subanalysis of a 2-year study.
    Overgaard K; Lindsay R; Christiansen C
    Clin Ther; 1995; 17(4):680-5. PubMed ID: 8565031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyclic therapy with intranasal carbocalcitonin in healthy spontaneous postmenopausal women.
    De Aloysio D; Pansini F; Campobasso C; Zanotti L; Abbruzzese AD; Mauloni M; Bottiglioni F
    Clin Exp Obstet Gynecol; 1996; 23(2):87-93. PubMed ID: 8737620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of calcitriol treatment with etidronate-calcitriol and calcitonin-calcitriol combinations in Turkish women with postmenopausal osteoporosis: a prospective study.
    Gürlek A; Bayraktar M; Gedik O
    Calcif Tissue Int; 1997 Jul; 61(1):39-43. PubMed ID: 9192511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.